Author

Pascal Verdier‐Pinard

Centre National de la Recherche ScientifiqueORCID 0000-0002-6149-6578Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cell Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Assay:imaging· 1 Organism:mouse· 1

Frequent Co-Authors

Abdellah Benjahad· 1 shared Alain Moussy· 1 shared Armelle GoubardiD· 1 shared Benoı̂t GigantiD· 1 shared Bérengère Hajem· 1 shared Camille MontersinoiD· 1 shared Christian Auclair· 1 shared Christophe LeterrieriD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCell Biology

Abdellah Benjahad

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cell BiologybioRxivPreprintJan 11, 2026

Direct labeling of microtubule turnover reveals in-lattice repair and stabilization patterns in developing neurons

Ciarán Butler-Hallissey, Harrison M. York, Florence Pelletier…·Christophe Leterrier

This study directly labels microtubule turnover in developing neurons, revealing in-lattice repair and stabilization patterns during axon formation.

DOI 10.64898/2026.01.11.698892

𝕏 PostBluesky

Cell BiologybioRxivPreprintDec 12, 2025

Identification of AB8939, a novel synthetic microtubule destabilizer and ALDH inhibitor that overcomes multidrug resistance in tumor cells as a drug candidate for the treatment of refractory acute myeloid leukemia

Martine Humbert, Sébastien Letard, Armelle Goubard…·Patrice C. Dubreuil

This paper identifies AB8939, a novel drug that targets microtubules and ALDH enzymes, showing efficacy against drug-resistant AML cells and models.

1 citation

humanexperimental assay

𝕏 PostBluesky